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Abstract
During recovery, stroke patients are at risk of developing long-term complications that impact quality of life, including changes in
body weight and composition, depression and anxiety, as well as an increased risk of subsequent vascular events. The aetiologies
and time-course of these post-stroke complications have not been extensively studied and are poorly understood. Therefore, we
assessed long-term changes in body composition, metabolic markers and behaviour after middle cerebral artery occlusion in
mice. These outcomes were also studied in the context of obesity, a common stroke co-morbidity proposed to protect against
post-stroke weight loss in patients. We found that stroke induced long-term changes in body composition, characterised by a
sustained loss of fat mass with a recovery of lean weight loss. These global changes in response to strokewere accompanied by an
altered lipid profile (increased plasma free fatty acids and triglycerides) and increased adipokine release at 60 days. After stroke,
the liver also showed histological changes indicative of liver damage and a decrease in plasma alanine aminotransferase (ALT)
was observed. Stroke induced depression and anxiety-like behaviours in mice, illustrated by deficits in exploration, nest building
and burrowing behaviours. When initial infarct volumes were matched between mice with and without comorbid obesity, these
outcomes were not drastically altered. Overall, we found that stroke induced long-term changes in depressive/anxiety-like
behaviours, and changes in plasma lipids, adipokines and the liver that may impact negatively on future vascular health.
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Introduction
Stroke is the leading cause of long-term disability in the UK,
chiefly due to the devastating effects of ischaemic brain damage
on the sensorimotor system. However, patients also develop other
complications that have a negative impact on recovery and reduce
their quality of life. In the days, weeks and months after stroke,
patients are at increased risk of infections and develop complica-
tions such as changes in body weight and appetite, depression,
fatigue, anxiety and/or cognitive impairment [1–4]. Stroke patients
are also at an increased risk for future vascular events [5, 6]. Very
little is known about the underlying mechanisms involved in post-
stroke complications but long-lasting changes in metabolism and
energy balance are likely key [7].
Weight loss in stroke patients is common and an important
determinant of outcome [8–10]. During the acute phase of
stroke, the nutritional status of patients worsens, resulting in
malnutrition that interferes with the recovery of patients’ ac-
tivities of daily living [11, 12]. Approximately 20% of surviv-
ing patients may then develop tissue wasting (cachexia),
characterised by loss of lean and fat tissue, with these patients
showing poor functional recovery compared to nutritionally
healthy patients [7]. Patients at high risk of malnutrition also
have a high risk of mortality at 6 months post-stroke [13], and
malnutrition and low body weight are both then risk factors
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for further stroke recurrence [14–17]. The reasons why pa-
tients experience weight loss after stroke are not entirely clear,
but are thought to include reduction in food intake and in-
creased catabolic drive. Stroke in mice can induce an acute
whole bodymetabolic response that involves changes in lipids
and adipokines in the liver, adipose tissue and plasma and
which could impact on energy balance and weight control
[18]. Adipokines such as resistin and adiponectin are released
from adipose tissue and early changes in both are reported in
mice after stroke, suggesting disturbances in metabolic status.
Adiponectin, resistin and lipids have also been linked to in-
creased stroke risk in people [19, 20]. However, whether these
acute changes in lipolysis and adipokines seen in experimental
stroke are long lasting is unknown, but prolonged alterations
in these physiological systems could potentially impact future
vascular health.
Conditions that affect metabolism, for example obesity and
diabetes, increase the risk of stroke and are thus common co-
morbidities found in stroke patients [21–24]. These conditions
may also affect the recovery from stroke, for example obesity
worsens acute experimental stroke outcome [25–28]. In con-
trast to clinical studies that monitor patient recovery over sev-
eral months, most of these studies in comorbid animals have
focused on acute time points (e.g. 24–72 h). In fact, some
clinical studies suggest obesity may actually be beneficial
for stroke recovery, the so-called obesity paradox, which leads
to reduced mortality in obese patients [14, 29]. One proposed
biological explanation for these epidemiological observations
is that excess energy stores in obesity protect against post-
stroke weight loss [30], thus preventing the harmful effects
of malnutrition on post-stroke recovery. However, whether
obesity affects weight loss, lipids and adipokine release, and
neurological recovery and behaviour after experimental stroke
in the long-term is poorly understood.
The aims of this study were to (i) establish the effect of
experimental stroke on depressive- and anxiety-like behav-
iours; long-term secondary complications commonly reported
in stroke patients and (ii) assess if stroke-induced prolonged
changes in weight loss, and adipokine and lipid status.




Male C57BL/6J mice (Envigo, UK) were used for all studies.
All animals were housed in individually ventilated cages in
standard housing conditions (temperature 21 ± 2 °C; humidity
55% ± 5%; 12-h light/12-h dark cycle), with access to food
and water ad libitum. At 8 weeks of age, cages of mice were
randomly assigned (using ‘rand()’ function of Microsoft
Excel) to either a high-fat diet (named obese; 60% energy
from fat, 58G9, Test Diets®, supplied by IPS Product
Supplies Ltd., UK) or a low-fat diet (named control; 12%
energy from fat, 58G7, Test Diets®, IPS Product Supplies
Ltd., UK) for 26 weeks prior to surgery [25]. All experiments
were conducted in accordance with the UK Animals
(Scientific Procedures) Act 1986 and approved by the local
Animal Welfare and Ethical Review Board, University of
Manchester, UK. All reporting of animal experiments com-
plied with the ARRIVE guidelines (Animal Research:
Reporting in In Vivo Experiments) [31].
Transient Middle Cerebral Artery Occlusion
Transient middle cerebral artery occlusion (MCAO) was used
to induce focal ischemia in the left cerebral hemisphere using
a protocol adapted from Longa et al. [32]. Anaesthesia was
induced with 4% isoflurane and maintained with 1.5% (30%
O2 and 70% N2O). Core body temperature was monitored
using a rectal probe and maintained at 37 ± 0.5 °C with a
homeothermic blanket (Harvard Apparatus, UK). The left ca-
rotid arteries were exposed and a silicone-coated filament
(coating 210 μm in diameter and 4–5-mm length, Doccol,
USA) was introduced into the external carotid artery and ad-
vanced along the internal carotid artery until occluding the
origin of the MCA. Successful MCAO was confirmed by a
reduction in cerebral blood flow of at least 80% as measured
using laser-Doppler (Moor Instruments, UK). High-fat diet
(for 6 months) is known to worsen ischaemic damage in ro-
dents after 30 min but not 20 minMCAO [25]. As the severity
of many outcome measures (e.g. post-stroke behavioural def-
icits) are likely to correlate with infarct volume, the greater
ischaemic damage seen after 30 min MCAO in obese high-fat
fed mice could be a potential confounding factor. Therefore, to
produce a similar volume of ischaemic damage between diet
groups, the MCAwas occluded for 20 min in obese mice (n =
10) and 30min in control mice (n = 19). To confirm that obese
mice have poorer outcome (as previously reported [25]), a
group of obese mice (n = 4) also underwent MCA for
30 min. After the respective occlusion times, the filament
was removed to allow reperfusion and the wound sutured.
Sham-operated mice (n = 10/diet group) underwent the same
procedure; however, once the filament had been inserted and
advanced to the MCA, it was immediately withdrawn. As we
aimed to match infarct volumes between diet groups and did
not have a pilot data for animals recovered to 60 days, we had
no pilot data onwhich to base power calculations. Therefore, a
standardised effect size was used for the power analysis, using
a Cohen’s d of 1.4. Using an alpha of 0.5 and a power of 0.8,
we found 10 animals per group would be required. However,
additional animals were used in anticipation of drop-out over
the 60-day recovery period due to the large infarcts expected.
Due to the obese phenotype, blinding could not be performed
838 Transl. Stroke Res. (2020) 11:837–850
during surgery, but all subsequent analyses were performed
blinded to diet and surgery. To facilitate nutrition for the first
2 days post-MCAO, all animals were given access to a soft
chow diet (BK001 E, Special Diets Services, UK), in addition
to their respective control and high-fat diets. Deficits in sen-
sorimotor function were assessed using a 28-point neuroscore
on days 2, 7, 14 and 51 post-MCAO, modified from proce-
dures described previously [33].
Due to animals reaching humane endpoints for animal suf-
fering [34], several animals were euthanised within 14 days of
surgery, some of which were euthanised prior to undergoing
magnetic resonance imaging (MRI) imaging: 8 control (of
which 3 had no MRI scan on day 2), 5 obese mice (20 min
MCAO) and 4 obese mice (30 min MCAO). One animal each
from the control 30 min and obese 20 min groups were ex-
cluded due to no stroke. No deaths or complications occurred
in sham-operated animals. Final numbers were control sham
n = 10, control MCAO/stroke n = 10, obese sham n = 10 and
obese MCAO/stroke (20 min) n = 4 and are detailed in the
figure legends.
Quantification of Infarct Volume/Oedema/Brain
Atrophy
Infarct volume and oedema were quantified at 48 h post-
MCAO, and brain atrophy at day 50 post-surgery by MRI.
Under isoflurane anaesthesia, MRI scans were taken with a
7T horizontal bore magnet (Agilent Technologies, UK)
interfaced to a BrukerAvance III console (Bruker Biospin,
UK) using a surface transmit-receive coil. Coronal pilot im-
ages were acquired to determine the correct geometry and
localise the brain (using a multi-scale gradient echo sequence).
T2-weighted TurboRARE high resolution images were taken
under the following parameters: matrix = 256 × 256, slice
thickness = 1 mm, interslice distance = 1 mm, resolution =
0.0156 cm/pixel, acquisition time = 5min 51 s. Infarct volume
at 48 h was calculated by measuring infarct area over 8 slices
in ImageJ (NIH, USA). Oedemawas calculated as the percent-
age difference between the volumes of the ipsilateral and con-
tralateral hemispheres. At day 50, atrophy was calculated as
the percentage reduction in the volume of the ipsilateral hemi-
sphere compared to the contralateral. Analyses of atrophy,
infarct volume and oedema were all performed blinded to
experimental groups by randomising file names.
Behavioural Phenotyping
Depressive-like behaviours were assessed in all mice using the
burrowing and nest building tests. For all tests, a baseline
measurement (day 0) was taken prior to surgery. Locomotor
activity and measures of anxiety were assessed using the open
field test. White noise was played throughout the tests to
minimise auditory cues, and all testing (except nest building)
was conducted during the light phase.
Burrowing
Burrowing ability was assessed in all mice on days 0, 3, 14
and 30 as adapted from Deacon et al. [35]. Briefly, burrows
were made from 20 cm piece of 68-mm diameter plastic
downpipe with one end sealed, 2.5-cm machine screws were
inserted at the other end to elevate the burrow 3 cm off the
cage floor. Mice were habituated to the burrowing arena (an
empty cage) for 30 min, before burrowing tubes, containing
700 g of gravel, were introduced and left for 1 h. After 1 h,
burrows were removed and remaining gravel was weighed to
calculate percentage burrowed.
Nest Building
Nest building ability was assessed in all mice on days 0, 3, 7,
14 and 30. Mice were individually housed with 140 g of wood
chippings and 20 g of sizzle nest building material equally
distributed throughout the cage, and food weighed. Mice were
left overnight and images were taken of the nests from above
and of the sides to determine depth and all mice returned to
home cages. Nests were scored based on Deacon’s standard-
ized scale [36], from 0 to 5. All images were blinded and
scored by two independent markers, an average score was
calculated and further analysed. The amount of food con-
sumed (kCal) during the dark phase was also calculated.
Open Field
On day 37, mice were placed individually into the centre of
a square opaque perspex box (45 cm × 30 cm × 45 cm) and
their behaviour recorded for 5 min. Apparatus was cleaned
with 70% ethanol between mice. Video recordings were
analysed with Stoelting ANY-maze v4.9 software and for
assessment of locomotion/activity the total distance (m)
moved, average speed (m/s), duration (sec) of mobile epi-
sodes were measured. For assessment of anxiety, the time
(sec) spent at the sides of the arena was measured and %
time spent at the sides calculated.
Body Composition Analysis
Body composition (adipose tissue and lean mass) was
assessed by nuclear magnetic resonance imaging (EchoMRI,
Echo Medical systems, USA) at days 0, 1, 3, 5, 7, 10, 14, 21,
42 and 49. Total body weight of animals was taken prior to
scanning. Net loss (g) in total body weight and adipose and
lean mass was calculated from day 0 (prior to stroke) and area
under the curve (g × days) for all time points.
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Tissue Preparation and Histology
At day 60, post-surgery mice were terminally anaesthetised
with 4–5% isoflurane (30% O2 and 70% N2O) and cardiac
blood taken before transcardial perfusion with phosphate
buffered saline (PBS). Plasma was obtained by centrifuga-
tion at 1200g for 10 min and epididymal fat removed and
both were frozen and stored at − 80 °C. Animals were then
transcardially perfused with 4% paraformaldehyde (PFA)
and the brain and liver were immerse fixed in PFA for 48 h.
The brain was sliced into 2-mm-thick sections using a met-
al brain matrix. Brain sections and the liver were embed-
ded in paraffin wax using a Shadon Citadel 2000 tissue
processor (Thermo Scientific, UK) and subsequently sec-
tioned into 5 μm sections using a Leica RM 2155
Microtome (Leica Microsystems Ltd., Germany) and
mounted on SuperFrost© Plus slides (Thermo Scientific,
UK). Brain and livers were deparaffinised in xylene
(followed by ethanol), stained with haemotaoxylin and eo-
sin and coverslipped using DPX mounting medium (Fisher
Scientific, UK). Hepatic steatosis (fatty vacuolation due to
accumulation of lipid) and hepatocyte injury (ballooning
degeneration and/or pale to clear cytoplasm) were semi-
quantitatively graded using the criteria adapted from that
previously described by Kleiner et al. [37]. For each pa-
rameter, six random fields of view were evaluated using
ImageJ by an experimenter blinded to the groups by
randomising file names.
Adipokine Analysis
Adipose tissue (from frozen epididymal fat) was
homogenised in buffer (50 mM Tris-HCl, 150 mM
NaCl, 5 mM CaCl2 and 0.02% NaN3) containing 1%
Triton-X and protease inhibitor cocktail 1 (Calbiochem,
UK). Five microlitres was added per milligram of tissue
sample (around 100 mg of tissue was used). Samples were
then homogenised using a T-10 Basic ULTRA-TURRAX
homogeniser (IKA, USA), briefly sonicated on ice with a
hand-held probe sonicator (IKA) and left on ice for
30 min. Samples were centrifuged at 14,000g for 30 mins
(4 °C). Supernatant was decanted and stored at − 20 °C.
Resistin, adiponectin and leptin in adipose tissue superna-
tant and plasma were analysed by enzyme-linked immu-
nosorbent assay (ELISA; R&D Systems, UK) according
to the manufacturer’s instructions. Adipokine concentra-
tions were determined by reference to the relevant stan-
dard curves. For adipose tissue, protein concentration was
assessed by a bicinchoninic protein assay (BCA; Pierce
Biotechnology, USA), and results expressed as pg or ng/
mg protein. For plasma, data are expressed as μg or
ng/ml/g fat weight.
Lipid Analysis and ALT Assay
Plasma levels of free fatty acids (FFAs; Zen-Bio Inc., USA)
and triglycerides (BioVision Inc., USA) were measured (in
mmol/l) using the relative assays according to the manufac-
turer’s instructions. Alanine aminotransferase (ALT) levels
were measured in the plasma using a colorimetric activity
assay kit (Cayman Chemical, USA).
Data and Statistical Analyses
Data are presented as mean ± standard deviation (SD), unless
indicated. Equal variance and normality were assessed with
the Brown–Forsythe and Shapiro–Wilk test respectively and
appropriate transformations were applied when necessary. For
discrete data and data with non-normal distributions
(neuroscore), generalised linear mixed modelling was used
(GLMM) with mouse I.D. as the random effect [38–40]. The
significance of inclusion of an independent variable or inter-
action terms was evaluated using log-likelihood ratio. Holm–
Šidák post hocs were then performed for pair-wise compari-
sons using the least square means [41]. Pearson residuals were
evaluated graphically using predicted vs level plots. All anal-
yses were performed using R (version 3.5.1) [42]. Linear
mixed effects models were used to assess the effects of diet
and stroke on depressive-like behaviour. The linear mixed
model function “lme” (nlme v1.1-9) was used to estimate
the effects of stroke and diet on outcome measures. All factors
and interactions were modelled as fixed effects. A within-
subject design with random intercepts and by-subject random
slopes for all effects was used, aiming for a maximal random
effects structure. Inclusion of fixed effect into the model was
evaluated using the log-likelihood ratio test. Modelling was
carried out using R (version 3.2.5). All other statistical analy-
ses were performed using GraphPad Prism v6 (GraphPad
Software Inc., USA) using the appropriate tests (as detailed
in the figure legends). p values < 0.05 were considered statis-
tically significant.
Results
Obese Mice with the Same Infarct Volume Showed No
Difference in Acute Outcome
Although obesity is a well-established risk factor for isch-
aemic stroke, it is more controversial as to whether obesity
worsens outcome in patients. We have shown previously
that with an occlusion time of 30 min, obesity (induced by
high-fat feeding) increases ischaemic damage after experi-
mental stroke in mice [25] and here, 30-min occlusion of
the MCA also produced severe ischaemic damage and all
mice (n = 4) had to be culled at day 2. To better model the
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clinical situation and avoid the confounding effect of dif-
ferences in infarct volumes between groups, the MCAwas
occluded for 20 min in obese mice, compared to 30 min in
control mice. There was no effect of sham surgery on sur-
vival in either diet group. There was no significant differ-
ence in survival between control mice undergoing a 30-min
occlusion, and obese mice undergoing a 20-min occlusion
(Fig. 1a). There was also no significant difference in infarct
volume or stroke-induced oedema between groups as mea-
sured by MRI at day 2, either in all mice including those
that died, or in survivors only (Fig. 1b, c).
MRI imaging at day 2 (Fig. 1d) showed large infarcts
present in both the striatum and cortex, and in some
cases extending into the hippocampus and thalamus. At
day 50, areas of hyperintensity on MRI were present
predominantly in the outer cortical regions. On histolog-
ical examination, these regions were cerebral spinal fluid
(CSF)-filled cavities devoid of brain tissue. Ventricular
enlargement and ipsilateral hemisphere atrophy were al-
so observed in both control and obese stroked animals,
with no significant difference in atrophy between groups
(Fig. 1e).
Sensorimotor function was assessed longitudinally
using neuroscore. Deficits in both groups were observed
up to 51 days post-stroke compared to sham animals (Fig.
1f). A significant effect of day (p < 0.001) was observed
after stroke in control and obese mice indicating function-
al improvement (a reduction in neuroscore) over time.
There was no effect of diet on neuroscore, and no inter-






















































































Fig. 1 Obese mice with the same infarct volume showed no difference in
outcome. C57BL/6J fed a control or high-fat (obese) diet for 6 months
underwent middle cerebral artery occlusion (MCAO; 30 min for control,
20 min for obese). Percent survival over 60 days (a). MRI imaging (T2
Turborare) was performed on all mice at day 2, and in survivors at day 50.
Infarct volume (b) and oedema (c) were quantified on day 2 using MRI
images (crossed symbols represent mice culled prior to day 50).
Representative MRI scans for both control and obese mice illustrating
ischemic damage on day 2 and ipsilateral hemisphere atrophy on day 50
(d). Representative images for both time points are from the same mouse
(scale bar = 0.38 cm). Atrophy in ipsilateral hemisphere was measured at
day 50 fromMRI scans (e). Neuroscore was measured at days 2, 7, 14 and
51 after surgery to assess sensorimotor deficits (f). Data are presented as
mean ± SD (a, b, c, e) or median and interquartile range (f). For (b) and
(c) n = 9–15 and (e) and (f) n = 4–10. Data were assessed using (a) a Log-
rank (Mantel-Cox) test, (b) unpaired t test, (c) and (e) one-sample t test
with hypothetical value of 0 within a group (where **p < 0.01,
***p < 0.001) and unpaired t test between groups, (f) generalised linear
mixed effects modelling followed by Holm–Šidák post hoc analysis
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Stroke Disrupts Spontaneous Behaviours in Mice
Both nest building and burrowing are behaviours engaged by
healthy mice without training, and so the loss of these behav-
iours can be used as indication of depressive-like behaviour.
Stroke induced deficits in both nest building (Fig. 2a) and
burrowing (Fig. 2b). The stroke-induced deficit in nest build-
ing was detectable up to 14 days post-stroke, with a maximal
reduction seen at 3 days. Mixed linear model analysis identi-
fied a main effect of stroke (χ21 =7.076, p < 0.008), but no
effect of diet, and no interaction between stroke and diet.
Deficits in burrowing behaviour were observed at 3 days
post-stroke compared to sham-operated control mice.
However, sham-operated obese mice also had significantly
reduced burrowing behaviour at day 3. Mixed linear model
analysis identified a main effect of both diet (χ21 =5.094,
p < 0.024) and stroke (χ21 =4.563, p < 0.033). An interaction
effect between stroke and diet was observed (χ21 =5.011,
p < 0.025), and between stroke and day (χ23 =13.284,
p < 0.004).
To determine if there were any changes in locomotion
or anxiety-like behaviours, open field analysis was per-
formed on day 37. No effect of diet or stroke was detected
on the total distance travelled, average speed or time mo-
bile (Fig. 3a–c). A significant main effect of diet and
stroke was observed on measures of anxiety (time spent
in the sides of arena), with stroke increasing anxious be-
haviour (Fig. 3d). No interaction effect between diet and
stroke was observed on any parameters assessed. To as-
sess working memory the Y-maze test was performed at
day 14 and 45. No memory impairment was observed
after stroke in either control or obese mice compared to
sham (Fig. S1).
Greater and Prolonged Adipose Tissue Loss in Obese
Mice After Stroke
Before surgery (MCAO or sham), mice fed a high-fat diet
had increased body weight and a higher percentage body
fat but reduced lean mass (Table 1) compared to mice fed
a control diet. After experimental stroke, both control and
obese mice showed a prolonged loss of body weight com-
pared to sham-operated mice (Fig. 4a, d, Table 1).
However, body weight loss was significantly greater in
obese mice. In both groups, post-stroke weight loss was
primarily due to a reduction in adipose tissue mass, with
obese mice losing significantly more adipose tissue (Fig.
4b, e). In comparison, lean mass reduced only transiently
in both stroke groups, and the extent of the loss was
similar between control and obese mice (Fig. 4c, f). In
neither group did infarct volume correlate with weight
loss (Fig. 4g). At day 14, when weight loss reached a
nadir after stroke, overnight food intake was significantly
greater compared to baseline (day 0) in both control-fed
sham and stroke mice, but no difference was seen between
day 0 and 14 in obese mice (Fig. 4h).










































Fig. 2 Stroke induces prolonged
depressive-like behaviours.
Depressive-like behaviours were
assessed by nest building (a) and
burrowing (b) on days: 0, 3, 7, 14
and 30 (not day 7 for burrowing)
post-stroke. Impaired nest build-
ing behaviour in control and
obese mice was observed up to
14 days after stroke, and at day 3
for burrowing, when obese sham
mice also showed a deficit. Data
are presented as mean ± SD (n =
4–10). **p < 0.01 and
***p < 0.001 control sham versus
control stroke; #p < 0.05 and
###p < 0.001 obese sham versus
obese stroke; $$p < 0.01 control
sham versus obese sham.
Statistical analysis was performed
using a linear mixed effects
models followed by Šidák–
Holmes post hoc analysis
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Stroke Induces a Prolonged Change in Adipokine
Production
In mice fed a control diet, stroke induced significant alter-
ations in adipokine production at 60 days post-stroke
(Fig. 5). Resistin concentrations were significantly increased
after stroke in the adipose tissue (Fig. 5a) and plasma (Fig.
5b), and adiponectin concentrations were increased in the
plasma (Fig. 5c). Leptin concentrations were unaffected by
stroke (Fig. 5c, f). The adipokine response to stroke was
similar in obese mice, though some differential effects were
observed. For example, stroke did not induce a significant
increase in resistin in the adipose tissue in obese mice. There
was no significant correlation between the extent of weight
loss and plasma adipokine levels after stroke in control or
obese mice (adiponectin; control r2 = 0.09, obese r2 = 0.32:
resistin; control r2 = 0.19, obese r2 = 0.29: leptin; control
r2 = 0.0002, obese r2 = 0.35). Obesity by itself (in the absence
of stroke) also affected adipokine production. Sham-operated




































































Fig. 3 Stroke induces behaviours indicative of anxiety. Locomotor
behaviour and measures of anxiety were assessed in the open field test
on day 37 and expressed for locomotion as (a) total distance moved, (b)
average speed, (c) time mobile, and for anxiety (d) percentage of time
spent at sides of arena. An increase in the amount of time spent at the sides
of the arena, indicating anxiety, was seen after stroke in control and obese
mice and also in obese mice after sham surgery. Data are presented as
mean ± SD (n = 4–10). *p < 0.05 for a main effect of stroke and diet.
Statistical analysis was performed using a two-way ANOVA followed
by Tukey’s post hoc multiple comparisons test
Table 1 Body composition
before and after stroke Control Obese
Sham Stroke Sham Stroke
Initial
Body weight 34.5 ± 5.8 34.0 ± 1.9 49.4 ± 1.7### 50.1 ± 3.9###
% fat 27.6 ± 13.2 28.5 ± 4.0 43.2 ± 2.2### 43.1 ± 3.2#
% lean 67.6 ± 12.2 67.3 ± 2.9 53.9 ± 2.2### 52.6 ± 1.9##
Final
Body weight 35.4 ± 5.7 28.9 ± 1.5* 47.6 ± 4.4### 34.9 ± 8.5***
% fat 27.7 ± 11.0 11.3 ± 5.0*** 35.6 ± 5.3 19.5 ± 8.9**
% lean 70.9 ± 8.7 79.9 ± 8.7 61.3 ± 4.5# 78.5 ± 9.3**
Mice were kept on a control diet or a high-fat diet (obese) for 6 months.Middle cerebral artery occlusion (MCAO;
30min for control and 20min for obese) to induce stroke, or sham surgery was performed. Bodyweight, and% fat
and lean tissue were assessed before and at day 50 after surgery by EchoMRI. Data are shown as mean values ±
S.D. (n = 4–10/group). Statistical analysis was performed using a two-wayANOVA followed by Tukey’s post hoc
multiple comparisons test. *p < 0.05, **p < 0.01, ***p < 0.001 versus surgery control on same diet and # p < 0.05,
## p < 0.01, ### p < 0.001 versus control diet for same surgery
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concentrations in the adipose tissue and plasma, and increased
concentrations of leptin in adipose tissue.
Stroke Induces a Prolonged Change in Plasma Lipids
and Liver Function
In mice fed a control diet, at 60 days after stroke, there
was a significant increase in plasma free fatty acids and
triglycerides (Fig. 6a, b). This effect was not seen in
obese mice, though sham-operated obese mice had higher
plasma triglycerides concentrations. In response to stroke
in either control or obese mice, there was no significant
correlation between weight loss and plasma free fatty
acids (control r2 = 0.00002, obese r2 = 0.26) or triglycer-
ides (control r2 = 0.05, obese r2 = 0.19).
Increases in liver triglycerides have previously been report-
ed 24 h after stroke inmice [18]. Livers were therefore taken at
day 60 and assessed histologically. Liver steatosis was ob-
served in sham-operated obese mice, though this effect was
lost in obese mice undergoing experimental stroke (Fig. 6c, e).
Stroke had no effect on liver steatosis in control-fed mice.
Hepatocyte injury was also measured using a scoring system,
with damaged hepatocytes being identified by their partial or
complete loss of cytoplasm, and condensed or swollen nuclei
(Fig. 6d, e). Stroke induced significant hepatocyte damage in
mice fed a control diet, though significant hepatocyte damage
was already observed in sham-operated obese mice, and so
stroke did not further increase hepatocyte damage in obese
mice. ALT was measured as an indicator of liver function
and was lower in both control and obese mice after a stroke
compared to sham groups (Fig. 6f).
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Fig. 4 Stroke induced a prolonged reduction in adipose tissue mass. Net
change in body weight (a), adipose/fat mass (b) and lean mass (c) in
grams were measured at baseline and days 1, 3, 5, 7, 10, 14, 21, 42 and
49 after stroke. Fat and lean masses were determined by EchoMRI. Area
under the curve was calculated for net change (d–f). A prolonged de-
crease in body weight due to loss of fat mass was observed in control
and obese mice after stroke with greater loss in obese mice. Stroke in-
duced a transient loss of lean mass in control and obese mice. No corre-
lationwas seen between bodyweight loss and infarct volume in control or
obese mice (g). Overnight food intake on day 14 relative to food intake
prior to surgery (day 0) (h) was significantly increased in control but not
obese groups. Data are shown as mean values ± SD (n = 4–10/group). For
AUC data, all groups were compared with a two-way ANOVA followed
by Tukey’s post hoc multiple comparisons test, where *p < 0.05,
**p < 0.01, ***p < 0.001. Difference in food intake was compared to a
hypothetical mean of 0 by one-sample t test (where *p < 0.05).
Correlation in (g) was performed using a linear regression
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Discussion
Here, we monitored the long-term metabolic and behavioural
effects of stroke, and the impact of the co-morbidity obesity
and demonstrate in control male mice long-lasting changes
that could indicate a risk for future vascular health.
Stroke patients commonly develop depression and anxiety,
which are barriers to recovery and rehabilitation [1, 3, 4].
Here, experimental stroke in mice induced prolonged changes
in behaviours that were measures of sickness behaviour, de-
pression and anxiety. Both nest building and burrowing be-
haviours were disrupted, two tests that exploit natural rodent
behaviours, which could also be surrogate markers for activ-
ities of daily living. Burrowing behaviour has classically been
employed as a measure of sickness behaviour in mouse
models of systemic inflammation and prion disease [43, 44],
but has also been suggested to measure attention and execu-
tive function [45]. Nest building, a complex goal-directed be-
haviour, has previously been used in models of schizophrenia
to study negative symptoms including impaired attention [46,
47]. The reasons that patients develop depression are complex
and poorly understood, though inflammation has been
hypothesised to play a role [48]. Inflammation is well under-
stood to drive sickness behaviour in rodents, which seems
phenotypically similar to depression, involving decreased
concentration, fatigue and anhedonia [49]. Prolonged anxiety
was also seen after stroke, as mice spent more time at the sides
of an open arena compared to the centre. It is unlikely that
impairment in motor activity contributed solely to these be-
havioural changes (especially nest building and burrowing)
after stroke as no changes in the distance moved or speed were
observed in the open field test. Furthermore, we observed no
deficits in nest building and burrowing at day 30 when there
was still an impairment in sensorimotor function assessed
using neuroscore. Some behaviours including burrowing have
been proposed to be affected by repeated anaesthesia in
healthy mice [50]. However, in the latter study, burrowing
was assessed 30 min post-anaesthesia compared to at least
24 h here. Burrowing was not impaired in control mice after
sham surgery, thus making it unlikely that anaesthesia contrib-
uted to the burrowing deficits in the present study.
Collectively therefore, by using these tests, we have demon-
strated that experimental stroke induced long-lasting changes
in behaviour that were relevant to those seen in stroke patients.
Weight loss and malnutrition are frequently observed in
patients with stroke and are associated with poor outcome
[7–10]. It was originally thought that weight loss is due pri-
marily to a reduction in lean mass, in particular muscle
wasting (sarcopenia) [51] but recent work also demonstrates







































































































Fig. 5 Stroke induces a prolonged change in adipokine production.
White adipose tissue (epididymal, a, c, e) and plasma (b, d, f) was
taken 60 days post-stroke and resistin (a–b), adiponectin (c–d) and leptin
(e–f) levels assessed by ELISA. In control mice, stroke caused an increase
in resistin in the adipose tissue and plasma, and an increase in plasma
adiponectin. An increase in plasma resistin and adiponectin was also seen
after stroke in obese mice. Adipose tissue concentrations were normalised
to microgram of total protein from BCA assay and plasma concentrations
normalised to total adipose mass. Data are presented as mean ± SD (n =
4–10). *p < 0.05, **p < 0.01 and ***p < 0.001. Statistical analysis was
performed using two-way ANOVA followed by Tukey’s post hoc multi-
ple comparisons test
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(examined ex vivo) have also been reported in rodents up to
7 days after experimental stroke [52–55]. These changes in
muscle mass appear to be transient as no differences were
observed between 2 and 14 weeks [56, 57]. Here, we compre-
hensively assessed the impact of stroke on body composition
in vivo up to 49 days post-stroke, observing a prolonged re-
duction in body weight that was due to a loss of fat mass. Lean
mass was also lost, but returned to pre-surgery levels by
21 days. The reason for this dramatic and prolonged weight
loss after stroke is unclear and could involve several mecha-
nisms, including reduced food intake and/or raised energy
expenditure, possibly via the action of inflammatory media-
tors. Acute weight loss after experimental stroke can correlate
positively with ischaemic damage [30, 58], although this cor-
relation is not always observed [18]. Here, the degree of
weight loss over 49 days did not directly correlate with initial
damage at 48 h, suggesting that post-stroke weight loss may
be caused by factors secondary to the initial injury, and
develop during recovery. Experimental models of stroke in-
volving permanent external carotid ligation have been pro-
posed to cause feeding difficulties that result in weight loss
[59, 60]. Although food intake is likely to be reduced in the
initial few days after stroke, we observed that when weight
loss was maximal (day 14), food intake was not different (in
obese) or increased (in controls) compared to pre-surgery,
which is in agreement with others showing no reduction in
food intake 7 days after stroke in mice [54]. Furthermore,
weight loss was significantly less in sham-operated mice
(compared to stroke) in which external carotid ligation was
also performed.
The long-term reduction in body fat we observed after ex-
perimental stroke was also accompanied by changes in lipid
metabolism. This effect was most pronounced in non-obese
animals, which showed increases in plasma free fatty acids
and triglycerides. Non-obese animals also had higher plasma























































































































Fig. 6 Stroke induces a
prolonged increase in plasma
lipids and change in liver
pathology and function. At 60 day
post-stroke, free fatty acids (a)
and triglycerides (b) were
assessed in the plasma. Liver
steatosis and injury were assessed
semi-quantitatively in tissue sec-
tions (c and d). Representative
images of liver (e) showing
steatosis (accumulation of fat) in
obese mice (asterisks), and liver
injury (ballooning of hepatocytes
and/or pale to clear cytoplasm;
arrow heads) in obese mice, and
in control-fed mice. Scale bar
100μm. Plasma ALT levels (f). In
control mice, stroke led to an in-
crease in plasma free fatty acids
and triglycerides, a decrease in
ALT, and caused a change in liver
pathology/injury. Raised triglyc-
erides, liver injury and lower ALT
were observed in obese mice after
sham or stroke surgery, while liv-
er steatosis seen in obese sham
mice was reduced after stroke.
Data are presented as mean ± SD
(a, b, f) or median and interquar-
tile range (c, d). (n = 4–10).
*p < 0.05 and **p < 0.01.
Statistical analysis was performed
using two-way ANOVA followed
by Tukey’s post hoc multiple
comparisons test for (a, b, f) and a
non-parametric Kruskal-Wallis
test followed by Dunn’s test for
multiple comparisons for (c, d)
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unlikely that weight loss alone caused these changes as there
was no correlation between the severity of weight loss and
plasma levels of these factors. In addition, healthy weight loss
is typically associated with a reduction in plasma free fatty
acids and triglycerides. Experimental stroke has been previ-
ously shown to acutely affect peripheral lipid metabolism,
potentially through the release of inflammatory mediators that
can promote a catabolic state [18], and can also exacerbate
atherosclerosis [61]. Together, these findings of lipid and
adipokine disturbance here suggest that experimental stroke
in non-obese mice resulted in long-lasting changes in metab-
olism, potentially originating in the adipose tissue. Changes in
plasma adipokines and lipids in patients after stroke have been
studied poorly, but a few studies report early increases in
resistin and triglycerides [62–64]. Whether these factors in
patients are high prior to stroke, and/or if they remain elevated
more chronically is unknown. Stroke patients are at an in-
creased risk of future vascular events, but it is not fully under-
stood why [5, 6]. However, altered blood lipids [65], increased
plasma resistin [20] and changes in adiponectin [66] have
been reported as risk factors for stroke. Similarly, being un-
derweight is a risk factor for stroke, and for poor stroke out-
come [14–17]. Therefore, prolonged weight loss after stroke
may result in a lipid and adipokine profile that increases the
risk of further vascular events.
After stroke, non-obese animals also showed prolonged
liver histological changes suggestive of liver injury. Previous
work has indicated liver damage and hepatocyte apoptosis
after stroke in high-fat fed rats, but only an acute time point
(24 h) was studied [67]. Liver damage is also reported in other
experimental models of injury including heart failure [68].
Within in the first 24 h after stroke in rodents, an increase in
chemokine and cytokine expression is observed in the liver,
which is accompanied by infiltration of neutrophils that could
potentially initiate damage [18, 25, 67, 69]. An increase in
liver triglyceride content is also seen 24 h after stroke in mice
[18]. It is not known if liver triglyceride levels are chronically
elevated in the present study, but this is unlikely as there was
no increase in liver steatosis after stroke when assessed histo-
logically. Liver damage is usually accompanied by an increase
in plasma ALT, and raised plasma ALT have been reported
between 3 and 24 h after stroke in rats [69, 70]. In contrast
here, plasma ALT levels were lower 60 days after stroke com-
pared to sham. However, low ALT blood levels have been
shown to be a marker of frailty and be associated with in-
creased risk of mortality and poorer long-term outcome in
the middle-aged and elderly, and patients with ischaemic heart
disease [71–76]. To our knowledge, chronic liver function has
not been studied in ischaemic stroke patients, but liver disease
is a co-morbidity and risk factor for stroke [77, 78] and lower
ALT at admission is a predictor of poor outcome at 3 months
[79]. Thus overall, these data suggest that experimental stroke
induced a prolonged change in liver function, but whether this
has a long-term consequence on health remains to be
determined.
Obese rodents have greater infarcts after experimental
stroke [25–27]. As the extent of ischaemic damage is the most
important determinant of acute sensory and motor outcomes,
it is also likely a key determinant of the longer-term outcomes
studied here. Therefore, to model the clinical situation in
which obese patients often do not have worse initial ischaemic
injury and outcome [80, 81], we used different MCA occlu-
sion times in our control and high-fat fed groups to match
initial ischaemic damage. Indeed, there was no significant
difference in infarct volume at 48 h or long-term survival up
to 60 days. Furthermore, there was also no influence of obe-
sity on the extent of odema, brain atrophy, physical impair-
ment (when assessed by neuroscore) or depressive and
anxiety-like symptoms. In contrast to the experimental stud-
ies, some clinical studies report an ‘obesity paradox’ where
obese stroke patients have reduced mortality and morbidity. A
hypothesised biological explanation for the ‘obesity paradox’
is that the greater metabolic reserves found in obese stroke
patients protect them from severe weight loss, especially loss
of lean tissue [28, 30]. In the present study, we found that
obese mice had a greater reduction in fat mass after stroke
compared to control mice. This could be partly due to food
intake, as food intake was not increased after stroke (at day 14)
in obese mice, and without a positive calorie balance the lost
weight will not be regained. Enhanced weight loss in obese
mice may also be driven by inflammatory cytokines that pro-
mote an enhanced anorexic response and/or raised metabolic
rate. Increases in inflammatory cytokines are observed in
obese mice after stroke in the plasma, liver and adipose tissue
[18, 25]. Obese mice also show an enhanced anorectic re-
sponse to lipopolysaccharide, which causes a greater andmore
prolonged reduction in food intake and body weight [82].
Besides losing more adipose weight after stroke, obese mice
showed an altered long-term disturbance in lipids and
adipokines compared to control mice, likely as obesity per
se resulted in metabolic abnormalities (e.g. increased plasma
lipids), which were similar to those found after stroke in con-
trol mice. Together, these data suggest that obesity did not
offer protection against weight loss after experimental stroke
or affect long-term behavioural changes.
In summary, stroke patients commonly develop secondary
complications in the weeks and months after stroke that neg-
atively affect their recovery and quality of life. However, these
complications are not well studied pre-clinically, and their
mechanisms are poorly understood. Here, we identified new
behavioural tools to assess secondary complications of stroke
such as depression. We also were the first to observe long-
term effects of stroke on metabolic markers. Specifically, our
data demonstrate that in both obese and control mice, lean
mass is only transiently reduced after stroke, whereas we ob-
served a long-term effect on fat mass. This reduction in fat
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mass in control mice was accompanied by changes in
adipokines and lipids, and potential changes in liver function.
Future work should determine if these findings in male mice
are also seen in females, and how they translate to stroke
patients. However, these data suggest stroke causes a lasting
effect on metabolism that could contribute to the increased
risk of recurrent vascular events seen in stroke patients.
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